Silke Gillessen Sommer

26PUBLICATIONS
243CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsEpidemiological modellingPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 09, 2026
PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Dec 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations.

Giuseppe Salfi, Martino Pedrani, Amos Colombo

|Aug 07, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier

|May 02, 2025
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer.

Sigrid V Carlsson, Pedro C Barata, Alan H Bryce

|Jan 11, 2025
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages.

Martino Pedrani, Jessica Barizzi, Giuseppe Salfi

Pageof 5

Frequent Collaborators

7 joint publications

Ricardo Pereira Mestre

6 joint publications

Matthew R Sydes

5 joint publications

Christopher Sweeney

4 joint publications

Alison J Birtle